Novel Variant of Tickborne Encephalitis Virus, Russia
Vladimir A. Ternovoi*, Elena V. Protopopova*, Eugene V. Chausov*, Dmitry V. Novikov†, Galina N. Leonova‡, Sergey V. Netesov*, and Valery B. Loktev*
Author affiliations: *State Research Center of Virology and Biotechnology “VECTOR,” Koltsovo, Novosibirsk Region, Russia; †Regional Clinical Hospital No. 1, Vladivostok, Russia; ‡Institute of Epidemiology and Microbiology, Vladivostok, Russia;
Figure 2. Growth curves and E protein synthesis of Glubinnoe/2004 and 205 in pig kidney embryo (PKE) cells: monolayer of PKE cells were infected with Glubinnoe/2004 and 205 of tickborne encephalitis virus (TBEV). The cells were frozen and thawed 3× to release the virus, and infectious titers were determined by the viral cytopathic effect (in 50% tissue culture infective doses [TCID50]/mL–1) assay in PKE cells. ELISA using 10H10 and biotin-labeled EB1 anti–protein E monoclonal antibodies was used to determine the E protein levels in virus-infected cells. 1, Glubinnoe/2004, virus yield; 2, 205, virus yield; 3, Glubinnoe/2004, E protein synthesis; 4, 205, E protein synthesis. Bars represent mean ± SD.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.